Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version of ...
The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...
Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva temporarily paused in January pending the appeal court’s decision to ...
Late last year we reported on the United States Court of Appeals for the Federal Circuit decision holding that certain device patents should not ...
Hosted on MSN10mon
Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (update)Avadel Pharmaceutical (NASDAQ:AVDL) rose 4.2% amid a hearing over the Federal Drug Administration's approval ... Patent), listed in the FDA’s Orange Book. "We're skeptical on JAZZ prevailing ...
Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the product’s approval – DEER PARK, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results